Caspase-1-processed IL-1 family cytokines play a vital role in driving innate IL-17

Cytokine

Volumn 56, Issue 1, 2011, Pages 126-132

  Dungan, Lara S ^a   Mills, Kingston H G ^a  

^a TRINITY COLLEGE DUBLIN   (Ireland)

Author keywords

T cells; IL 1 ; IL 17; IL 18; INKT cells

Indexed keywords

CALGRANULIN; CYTOKINE; CYTOKINE RECEPTOR; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 17; INTERLEUKIN 18; INTERLEUKIN 18 RECEPTOR; INTERLEUKIN 18 RECEPTOR ALPHA; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 1BETA CONVERTING ENZYME; INTERLEUKIN 22; LIPOCALIN 1; MATRIX METALLOPROTEINASE; STRUCTURAL PROTEIN; TOLL LIKE RECEPTOR 1;

ANIMAL CELL; ANTIGEN RECOGNITION; AUTOIMMUNITY; EPITHELIUM CELL; IMMUNE SYSTEM; IMMUNOCOMPETENT CELL; INNATE IMMUNITY; MEMORY CELL; MOUSE; NATURAL KILLER T CELL; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE; TIGHT JUNCTION;

ANIMALS; CASPASE 1; HUMANS; IMMUNITY, INNATE; INTERLEUKIN-1; INTERLEUKIN-17; PROTEIN PROCESSING, POST-TRANSLATIONAL; RECEPTORS, INTERLEUKIN-1;

EID: 80052762842     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2011.07.007     Document Type: Review

References (70)

1. Lomedico P.T., Gubler U., Hellmann C.P., Dukovich M., Giri J.G., Pan Y.C., et al. Cloning and expression of murine interleukin-1 cDNA in Escherichia coli. Nature 1984, 312:458-462.
2. Dinarello C.A. Interleukin-1 in the pathogenesis and treatment of inflammatory diseases. Blood 2011, 117:3720-3732.
3. Rouvier E., Luciani M.F., Mattei M.G., Denizot F., Golstein P. CTLA-8, cloned from an activated T cell, bearing AU-rich messenger RNA instability sequences, and homologous to a herpesvirus saimiri gene. J Immunol 1993, 150:5445-5456.
4. Michel M.L., Keller A.C., Paget C., Fujio M., Trottein F., Savage P.B., et al. Identification of an IL-17-producing NK1.1(neg) iNKT cell population involved in airway neutrophilia. J Exp Med 2007, 204:995-1001.
5. Hayday A.C. Gammadelta T cells and the lymphoid stress-surveillance response. Immunity 2009, 31:184-196.
6. Colotta F., Re F., Muzio M., Bertini R., Polentarutti N., Sironi M., et al. Interleukin-1 type II receptor: a decoy target for IL-1 that is regulated by IL-4. Science 1993, 261:472-475.
7. Kim S.H., Eisenstein M., Reznikov L., Fantuzzi G., Novick D., Rubinstein M., et al. Structural requirements of six naturally occurring isoforms of the IL-18 binding protein to inhibit IL-18. Proc Natl Acad Sci USA 2000, 97:1190-1195.
8. Novick D., Kim S.H., Fantuzzi G., Reznikov L.L., Dinarello C.A., Rubinstein M. Interleukin-18 binding protein: a novel modulator of the Th1 cytokine response. Immunity 1999, 10:127-136.
9. Dunne A., Ross P.J., Pospisilova E., Masin J., Meaney A., Sutton C.E., et al. Inflammasome activation by adenylate cyclase toxin directs Th17 responses and protection against Bordetella pertussis. J Immunol 2010, 185:1711-1719.
10. Martinon F., Agostini L., Meylan E., Tschopp J. Identification of bacterial muramyl dipeptide as activator of the NALP3/cryopyrin inflammasome. Curr Biol 2004, 14:1929-1934.
11. Kanneganti T.D., Ozoren N., Body-Malapel M., Amer A., Park J.H., Franchi L., et al. Bacterial RNA and small antiviral compounds activate caspase-1 through cryopyrin/Nalp3. Nature 2006, 440:233-236.
12. Mariathasan S., Weiss D.S., Newton K., McBride J., O'Rourke K., Roose-Girma M., et al. Cryopyrin activates the inflammasome in response to toxins and ATP. Nature 2006, 440:228-232.
13. Eisenbarth S.C., Colegio O.R., O'Connor W., Sutterwala F.S., Flavell R.A. Crucial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvants. Nature 2008, 453:1122-1126.
14. Dostert C., Petrilli V., Van Bruggen R., Steele C., Mossman B.T., Tschopp J. Innate immune activation through Nalp3 inflammasome sensing of asbestos and silica. Science 2008, 320:674-677.
15. Martin B., Hirota K., Cua D.J., Stockinger B., Veldhoen M. Interleukin-17-producing gammadelta T cells selectively expand in response to pathogen products and environmental signals. Immunity 2009, 31:321-330.
16. Shibata K., Yamada H., Hara H., Kishihara K., Yoshikai Y. Resident Vdelta1+ gammadelta T cells control early infiltration of neutrophils after Escherichia coli infection via IL-17 production. J Immunol 2007, 178:4466-4472.
17. Umemura M., Yahagi A., Hamada S., Begum M.D., Watanabe H., Kawakami K., et al. IL-17-mediated regulation of innate and acquired immune response against pulmonary Mycobacterium bovis bacille Calmette-Guerin infection. J Immunol 2007, 178:3786-3796.
18. Lockhart E., Green A.M., Flynn J.L. IL-17 production is dominated by gammadelta T cells rather than CD4 T cells during Mycobacterium tuberculosis infection. J Immunol 2006, 177:4662-4669.
19. Hamada S., Umemura M., Shiono T., Tanaka K., Yahagi A., Begum M.D., et al. IL-17A produced by gammadelta T cells plays a critical role in innate immunity against listeria monocytogenes infection in the liver. J Immunol 2008, 181:3456-3463.
20. Jensen K.D., Su X., Shin S., Li L., Youssef S., Yamasaki S., et al. Thymic selection determines gammadelta T cell effector fate: antigen-naive cells make interleukin-17 and antigen-experienced cells make interferon gamma. Immunity 2008, 29:90-100.
21. Spahn T.W., Issazadah S., Salvin A.J., Weiner H.L. Decreased severity of myelin oligodendrocyte glycoprotein peptide 33-35-induced experimental autoimmune encephalomyelitis in mice with a disrupted TCR delta chain gene. Eur J Immunol 1999, 29:4060-4071.
22. Roark C.L., French J.D., Taylor M.A., Bendele A.M., Born W.K., O'Brien R.L. Exacerbation of collagen-induced arthritis by oligoclonal, IL-17-producing gamma delta T cells. J Immunol 2007, 179:5576-5583.
23. Nanno M., Kanari Y., Naito T., Inoue N., Hisamatsu T., Chinen H., et al. Exacerbating role of gammadelta T cells in chronic colitis of T-cell receptor alpha mutant mice. Gastroenterology 2008, 134:481-490.
24. Prinz I., Sansoni A., Kissenpfennig A., Ardouin L., Malissen M., Malissen B. Visualization of the earliest steps of gammadelta T cell development in the adult thymus. Nat Immunol 2006, 7:995-1003.
25. von Boehmer H., Aifantis I., Gounari F., Azogui O., Haughn L., Apostolou I., et al. Thymic selection revisited: how essential is it?. Immunol Rev 2003, 191:62-78.
26. Schild H., Mavaddat N., Litzenberger C., Ehrich E.W., Davis M.M., Bluestone J.A., et al. The nature of major histocompatibility complex recognition by gamma delta T cells. Cell 1994, 76:29-37.
27. Weintraub B.C., Jackson M.R., Hedrick S.M. Gamma delta T cells can recognize nonclassical MHC in the absence of conventional antigenic peptides. J Immunol 1994, 153:3051-3058.
28. Scotet E., Martinez L.O., Grant E., Barbaras R., Jeno P., Guiraud M., et al. Tumor recognition following Vgamma9Vdelta2 T cell receptor interactions with a surface F1-ATPase-related structure and apolipoprotein A-I. Immunity 2005, 22:71-80.
29. Johnson R.M., Lancki D.W., Sperling A.I., Dick R.F., Spear P.G., Fitch F.W., et al. A murine CD4-, CD8- T cell receptor-gamma delta T lymphocyte clone specific for herpes simplex virus glycoprotein I. J Immunol 1992, 148:983-988.
30. Born W.K., Zhang L., Nakayama M., Jin N., Chain J.L., Huang Y., et al. Peptide antigens for gamma/delta T cells. Cell Mol Life Sci 2011, 68:2335-2343.
31. Morita C.T., Lee H.K., Wang H., Li H., Mariuzza R.A., Tanaka Y. Structural features of nonpeptide prenyl pyrophosphates that determine their antigenicity for human gamma delta T cells. J Immunol 2001, 167:36-41.
32. McCandless E.E., Budde M., Lees J.R., Dorsey D., Lyng E., Klein R.S. IL-1R signaling within the central nervous system regulates CXCL12 expression at the blood-brain barrier and disease severity during experimental autoimmune encephalomyelitis. J Immunol 2009, 183:613-620.
33. Lalor S.J., Dungan L.S., Sutton C.E., Basdeo S.A., Fletcher J.M., Mills K.H. Caspase-1-processed cytokines IL-1{beta} and IL-18 promote IL-17 production by GAMMA}{delta and CD4 T cells that mediate autoimmunity. J Immunol 2011, 186:5738-5748.
34. Ito Y., Usui T., Kobayashi S., Iguchi-Hashimoto M., Ito H., Yoshitomi H., et al. Gamma/delta T cells are the predominant source of interleukin-17 in affected joints in collagen-induced arthritis, but not in rheumatoid arthritis. Arthritis Rheum 2009, 60:2294-2303.
35. Sutton C.E., Lalor S.J., Sweeney C.M., Brereton C.F., Lavelle E.C., Mills K.H. Interleukin-1 and IL-23 induce innate IL-17 production from gammadelta T cells, amplifying Th17 responses and autoimmunity. Immunity 2009, 31:331-341.
36. Lochner M., Peduto L., Cherrier M., Sawa S., Langa F., Varona R., et al. In vivo equilibrium of proinflammatory IL-17+ and regulatory IL-10+ Foxp3+ RORgamma t+ T cells. J Exp Med 2008, 205:1381-1393.
37. Gutcher I., Urich E., Wolter K., Prinz M., Becher B. Interleukin 18-independent engagement of interleukin 18 receptor-alpha is required for autoimmune inflammation. Nat Immunol 2006, 7:946-953.
38. Meeks K.D., Sieve A.N., Kolls J.K., Ghilardi N., Berg R.E. IL-23 is required for protection against systemic infection with Listeria monocytogenes. J Immunol 2009, 183:8026-8034.
39. Cua D.J., Sherlock J., Chen Y., Murphy C.A., Joyce B., Seymour B., et al. Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature 2003, 421:744-748.
40. Kawano T., Cui J., Koezuka Y., Toura I., Kaneko Y., Motoki K., et al. CD1d-restricted and TCR-mediated activation of valpha14 NKT cells by glycosylceramides. Science 1997, 278:1626-1629.
41. Bendelac A., Savage P.B., Teyton L. The biology of NKT cells. Annu Rev Immunol 2007, 25:297-336.
42. Pichavant M., Goya S., Meyer E.H., Johnston R.A., Kim H.Y., Matangkasombut P., et al. Ozone exposure in a mouse model induces airway hyperreactivity that requires the presence of natural killer T cells and IL-17. J Exp Med 2008, 205:385-393.
43. Doisne J.M., Becourt C., Amniai L., Duarte N., Le Luduec J.B., Eberl G., et al. Skin and peripheral lymph node invariant NKT cells are mainly retinoic acid receptor-related orphan receptor (gamma)t+ and respond preferentially under inflammatory conditions. J Immunol 2009, 183:2142-2149.
44. Rachitskaya A.V., Hansen A.M., Horai R., Li Z., Villasmil R., Luger D., et al. Cutting edge: NKT cells constitutively express IL-23 receptor and RORgammat and rapidly produce IL-17 upon receptor ligation in an IL-6-independent fashion. J Immunol 2008, 180:5167-5171.
45. Doisne J.M., Soulard V., Becourt C., Amniai L., Henrot P., Havenar-Daughton C., et al. Cutting edge: crucial role of IL-1 and IL-23 in the innate IL-17 response of peripheral lymph node NK1.1- invariant NKT cells to bacteria. J Immunol 2011, 186:662-666.
46. Campillo-Gimenez L., Cumont M.C., Fay M., Kared H., Monceaux V., Diop O., et al. AIDS progression is associated with the emergence of IL-17-producing cells early after simian immunodeficiency virus infection. J Immunol 2010, 184:984-992.
47. Leite-De-Moraes M.C., Hameg A., Pacilio M., Koezuka Y., Taniguchi M., Van Kaer L., et al. IL-18 enhances IL-4 production by ligand-activated NKT lymphocytes: a pro-Th2 effect of IL-18 exerted through NKT cells. J Immunol 2001, 166:945-951.
48. Leite-De-Moraes M.C., Hameg A., Arnould A., Machavoine F., Koezuka Y., Schneider E., et al. A distinct IL-18-induced pathway to fully activate NK T lymphocytes independently from TCR engagement. J Immunol 1999, 163:5871-5876.
49. Pepper M., Jenkins M.K. Origins of CD4(+) effector and central memory T cells. Nat Immunol 2011, 131:467-471.
50. Aggarwal S., Ghilardi N., Xie M.H., de Sauvage F.J., Gurney A.L. Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17. J Biol Chem 2003, 278:1910-1914.
51. Fossiez F., Djossou O., Chomarat P., Flores-Romo L., Ait-Yahia S., Maat C., et al. T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines. J Exp Med 1996, 183:2593-2603.
52. Prause O., Laan M., Lotvall J., Linden A. Pharmacological modulation of interleukin-17-induced GCP-2-, GRO-alpha- and interleukin-8 release in human bronchial epithelial cells. Eur J Pharmacol 2003, 462:193-198.
53. Laan M., Cui Z.H., Hoshino H., Lotvall J., Sjostrand M., Gruenert D.C., et al. Neutrophil recruitment by human IL-17 via C-X-C chemokine release in the airways. J Immunol 1999, 162:2347-2352.
54. Huang F., Kao C.Y., Wachi S., Thai P., Ryu J., Wu R. Requirement for both JAK-mediated PI3K signaling and ACT1/TRAF6/TAK1-dependent NF-kappaB activation by IL-17A in enhancing cytokine expression in human airway epithelial cells. J Immunol 2007, 179:6504-6513.
55. Cua D.J., Tato C.M. Innate IL-17-producing cells: the sentinels of the immune system. Nat Rev Immunol 2010, 10:479-489.
56. Kao C.Y., Chen Y., Thai P., Wachi S., Huang F., Kim C., et al. IL-17 markedly up-regulates beta-defensin-2 expression in human airway epithelium via JAK and NF-kappaB signaling pathways. J Immunol 2004, 173:3482-3491.
57. Chen Y., Thai P., Zhao Y.H., Ho Y.S., DeSouza M.M., Wu R. Stimulation of airway mucin gene expression by interleukin (IL)-17 through IL-6 paracrine/autocrine loop. J Biol Chem 2003, 278:17036-17043.
58. Liang S.C., Tan X.Y., Luxenberg D.P., Karim R., Dunussi-Joannopoulos K., Collins M., et al. Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides. J Exp Med 2006, 203:2271-2279.
59. Shen F., Hu Z., Goswami J., Gaffen S.L. Identification of common transcriptional regulatory elements in interleukin-17 target genes. J Biol Chem 2006, 281:24138-24148.
60. Goetz D.H., Holmes M.A., Borregaard N., Bluhm M.E., Raymond K.N., Strong R.K. The neutrophil lipocalin NGAL is a bacteriostatic agent that interferes with siderophore-mediated iron acquisition. Mol Cell 2002, 10:1033-1043.
61. Zheng Y., Valdez P.A., Danilenko D.M., Hu Y., Sa S.M., Gong Q., et al. Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens. Nat Med 2008, 14:282-289.
62. Kinugasa T., Sakaguchi T., Gu X., Reinecker H.C. Claudins regulate the intestinal barrier in response to immune mediators. Gastroenterology 2000, 118:1001-1011.
63. Ogawa A., Andoh A., Araki Y., Bamba T., Fujiyama Y. Neutralization of interleukin-17 aggravates dextran sulfate sodium-induced colitis in mice. Clin Immunol 2004, 110:55-62.
64. Chabaud M., Garnero P., Dayer J.M., Guerne P.A., Fossiez F., Miossec P. Contribution of interleukin 17 to synovium matrix destruction in rheumatoid arthritis. Cytokine 2000, 12:1092-1099.
65. Takatori H., Kanno Y., Watford W.T., Tato C.M., Weiss G., Ivanov I.I., et al. Lymphoid tissue inducer-like cells are an innate source of IL-17 and IL-22. J Exp Med 2009, 206:35-41.
66. Passos S.T., Silver J.S., O'Hara A.C., Sehy D., Stumhofer J.S., Hunter C.A. IL-6 promotes NK cell production of IL-17 during toxoplasmosis. J Immunol 2010, 184:1776-1783.
67. Li L., Huang L., Vergis A.L., Ye H., Bajwa A., Narayan V., et al. IL-17 produced by neutrophils regulates IFN-gamma-mediated neutrophil migration in mouse kidney ischemia-reperfusion injury. J Clin Invest 2010, 120:331-342.
68. Hoshino A., Nagao T., Nagi-Miura N., Ohno N., Yasuhara M., Yamamoto K., et al. MPO-ANCA induces IL-17 production by activated neutrophils in vitro via classical complement pathway-dependent manner. J Autoimmun 2008, 31:79-89.
69. Meng G., Zhang F., Fuss I., Kitani A., Strober W. A mutation in the Nlrp3 gene causing inflammasome hyperactivation potentiates Th17 cell-dominant immune responses. Immunity 2009, 30:860-874.
70. Buonocore S., Ahern P.P., Uhlig H.H., Ivanov I.I., Littman D.R., Maloy K.J., et al. Innate lymphoid cells drive interleukin-23-dependent innate intestinal pathology. Nature 2010, 464:1371-1375.